Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Breakthrough measures Parkinson's progression in brain

  • Study identifies possible role for carbon monoxide in treating hemorrhagic stroke

  • Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies

  • New findings about mechanisms underlying chronic pain reveal novel therapeutic strategies

  • Clinical trial reduces stress of cancer caregivers

  • Communication made easier for children with cerebral palsy

  • Motherhood permanently alters brain and its response to hormone therapy later in life

  • New insights could result in changes to the therapeutic strategy to combat Alzheimer's, reduce animal testing

  • Can a little loving kindness improve our mental health?

  • Special fats proven essential for brain growth

  •